Chen Y.-C.Hsiao C.-H.TSEN-FANG TSAI2020-10-222020-10-2220080007-0963https://www.scopus.com/inward/record.uri?eid=2-s2.0-42049086557&doi=10.1111%2fj.1365-2133.2008.08469.x&partnerID=40&md5=28fe62fdb1d37995c26a4760d092af84https://scholars.lib.ntu.edu.tw/handle/123456789/517704[SDGs]SDG3alkaline phosphatase; alpha 2 globulin; anticonvulsive agent; antidepressant agent; antihistaminic agent; antilipemic agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; CD3 antigen; CD56 antigen; dipeptidyl carboxypeptidase inhibitor; diuretic agent; enalapril maleate; mucin; nonsteroid antiinflammatory agent; sennoside; tamsulosin; terazosin; tumor necrosis factor alpha inhibitor; aged; angioneurotic edema; case report; CD8+ T lymphocyte; delayed hypersensitivity; drug eruption; drug induced disease; drug withdrawal; erythema; erythroderma; granulomatous inflammation; human; inguinal lymph node; letter; liver function; male; priority journal; psoriasis; rash; remission; Aged; Angiotensin-Converting Enzyme Inhibitors; Dermatitis, Exfoliative; Drug Eruptions; Enalapril; Granuloma; Humans; Hypertension; Maleletter10.1111/j.1365-2133.2008.08469.x182843842-s2.0-42049086557